Quarterly ResultMay 6, 2026, 09:07 AM
Elanco Q1 Revenue $1.37B (+14.9%); Net Income $57M; EPS $0.11
AI Summary
Elanco Animal Health reported first-quarter 2026 revenue of $1.37 billion, a 14.9% increase year-over-year, driven by growth in both Pet Health and Farm Animal segments. However, net income decreased to $57 million from $67 million in the prior year, with diluted EPS falling to $0.11. The company also completed the acquisition of AHV International in April 2026 for $76 million upfront, expanding its farm animal health portfolio, and had a securities class action lawsuit dismissed.
Key Highlights
- Q1 2026 Revenue increased 14.9% to $1.37 billion from $1.19 billion year-over-year.
- Q1 2026 Net income decreased to $57 million from $67 million year-over-year.
- Q1 2026 Diluted EPS was $0.11, down from $0.13 in the prior year.
- Completed acquisition of AHV International for $76 million upfront, expanding farm animal health.
- Pet Health revenue grew to $710 million from $635 million year-over-year.
- Farm Animal revenue increased to $642 million from $546 million year-over-year.
- Net cash provided by operating activities improved to $13 million from $(4) million year-over-year.
- Court granted motion to dismiss securities class action lawsuit (Barpar) on March 26, 2026.